Cargando…
Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic
Correctional facilities are among the highest-risk settings for the spread of COVID-19. Prior to the COVID-19 pandemic, the Hennepin County Jail in Minneapolis, Minnesota, offered short-term methadone maintenance, buprenorphine initiation and maintenance, and naltrexone initiation and maintenance to...
Autores principales: | Duncan, Alexandra, Sanders, Noah, Schiff, Maria, Winkelman, Tyler N.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543710/ https://www.ncbi.nlm.nih.gov/pubmed/33371945 http://dx.doi.org/10.1016/j.jsat.2020.108161 |
Ejemplares similares
-
Estimated Use of Prescription Medications Among Individuals Incarcerated in Jails and State Prisons in the US
por: Curran, Jill, et al.
Publicado: (2023) -
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail
por: Velasquez, Melissa, et al.
Publicado: (2019) -
Trends in Buprenorphine Use in US Jails and Prisons From 2016 to 2021
por: Thakrar, Ashish P., et al.
Publicado: (2021) -
Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
por: Lee, Joshua D., et al.
Publicado: (2021) -
Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study
por: Cheng, Anna, et al.
Publicado: (2022)